NCT01918202 - A Study To Evaluate The PDE10 Enzyme Occupancy Following A Single Dose Of PF-02545920 In Healthy Male Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Healthy

Interventions

DRUG

20 mg PF-02545920

Subject will receive a single dose of 20 mg PF-02545920.

DRUG

PF-02545920

"The dose will be selected based on the results obtained for Cohort 1. Dose options range from 30 mg to 10 mg, 5 mg, 2mg, 1 mg.~This cohort is optional."

DRUG

PF-02545920

The dose will be selected based on the results obtained for Cohort 1 and cohort 2.

Trial Locations (1)

SE- 141 86

Karolinska Trial Alliance (KTA) M62, Huddinge